Eurofins announces successful closing of the transaction for a majority stake in IPL SED Nord and IPL Invest
04-11-2011: Eurofins Scientific announces the successful closing of the transaction for a 67% majority stake in each of the two subsidiaries of the Fondation Institut Pasteur de Lille (IPL), namely IPL Invest and IPL Santé Environnement Durable Nord (IPL SED Nord), on the 31st of October, 2011.
As previously communicated, the IPL SED Group is the leader in the French water testing market, and generates combined annual revenues of approximately EUR 45m. The transaction therefore reinforces Eurofins’ position as the leading service provider in the French environmental testing market. Both groups have already commenced planning a commercial and technical cooperation to combine their expertise in environmental analysis in anticipation of the integration.
As part of the agreement, no further details of the transaction will be disclosed.
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2Almost as sensitive as a dog's nose
- 3Three-dimensional model of bacterium
- 4Raman keeps lipstick evidence in the bag
- 5Do you want to know how much caffeine is in your drink?
- 6Breakthrough in DNA editing technology
- 73D IR images now in full color
- 8PIAB announces new Chief Executive Officer
- 9‘Forensic fingers’ for crime scene investigation
- 10Raman pixel by pixel
- Evonik and LanzaTech working on bio-processed precursors for specialty plastics
- Roche and Molecular Partners enter into alliance
- Merck’s new spin-off to focus on infertility treatment
- CHEMIE.DE gives technological support for the launch of a food and beverages ...
- Anton Paar GmbH acquires CSM Instruments
- Ghent University and MDxHealth Collaborate to Establish a Center in Pharmaco (Epi)genomics
- Pacific Biosciences and Imec Announce Collaboration to Develop Advanced Microchips for Single Molecule Sequencing Applications
- Trinean appoints new CEO and secures 2.7 million euro financing
- Pepric, a spin-off of imec, successfully concluded a EURO 1.4 million capital round.
- VIB scientists present method to reduce error rate in detecting genomic variants by short-read sequencing